Hyundai Bioscience Co. Ltd (048410) — Free Cash Flow Generation Index
Hyundai Bioscience Co. Ltd (048410) has a Free Cash Flow Generation Index of -1.81x as of December 2024. Free cash flow of ₩-4.09 Billion represents -2% of operating cash flow (₩2.26 Billion). See Hyundai Bioscience Co. Ltd short-term liquidity ratio to evaluate short-term liquidity relative to the company's equity base.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Hyundai Bioscience Co. Ltd Free Cash Flow Generation Index (2008–2024)
Historical FCF Generation Index trend for Hyundai Bioscience Co. Ltd across 8 annual periods. Explore Hyundai Bioscience Co. Ltd cash debt coverage ratio to assess how comfortably operating cash covers total debt obligations.
Annual Free Cash Flow Generation for Hyundai Bioscience Co. Ltd (2008–2024)
Year-by-year Free Cash Flow Generation Index for Hyundai Bioscience Co. Ltd. For the full company profile including market capitalisation, see 048410 market cap.
| Year | FCG Index | Free Cash Flow (KRW) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.04x | ₩87.48 Million | ₩2.26 Billion | ₩2.17 Billion | ▲ +101.6% |
| 2020 | -2.36x | ₩-17.70 Billion | ₩7.50 Billion | ₩25.20 Billion | ▼ -433.3% |
| 2019 | -0.44x | ₩-4.06 Billion | ₩9.18 Billion | ₩3.07 Billion | ▼ -118.3% |
| 2018 | 2.41x | ₩12.07 Billion | ₩5.01 Billion | ₩7.07 Billion | ▼ -71.3% |
| 2015 | 8.41x | ₩734.93 Million | ₩87.36 Million | ₩647.57 Million | ▲ +398.9% |
| 2014 | 1.69x | ₩2.06 Billion | ₩1.22 Billion | ₩840.18 Million | ▲ +58.0% |
| 2011 | 1.07x | ₩4.24 Billion | ₩3.97 Billion | ₩267.78 Million | ▼ -22.5% |
| 2008 | 1.38x | ₩14.29 Billion | ₩10.37 Billion | ₩3.92 Billion | — |